Concordia International United Kingdom

Ms Olivia Ceulemans
Senior Business Development Manager 
Mr Jujhar Chima
Business Development Alliance Managers 

Consilient Health United Kingdom

Ms Jeanette Evans
Chief Business Development Officer 

Csendes Consulting Switzerland

Dr Ivan Csendes

Debiopharm International SA Switzerland

Dr Fabien Sebille
Director Business Development, Licensing Marketing & Communication 
Dr Fabrice Paradies
Director Industrial Business Develpment & Global Commercial Alliances 

Desma Healthcare Switzerland

Dr M. Cristina Armandola
B&D Manager 

Dr. M. Newzella GmbH Germany

Dr. M. Newzella GmbH is an international personnel and business consulting company active within the fields of pharmaceuticals and health care and specializing in the areas of Executive Search, Merger & Acquisition and Product & Licensing.

Thanks to its 35 years of branch experience, Dr. Newzella Consulting has built up an extensive international network of excellent business contacts and has far-reaching knowledge of both companies and markets to supports its clients with individual, flexible and high performance services.

Dr Christoph Newzella
Dr Christoph Newzella
Managing Partner & Director Management Consulting 
Dr Matthias Newzella
Dr Matthias Newzella
Managing Partner, Director Management Consulting & Head of Executive Search 

Dr. Willmar Schwabe GmbH & Co KG Germany

Cornel Martin
Head of Business Development & Licensing 

EGAMID LTD United Kingdom



Ms Susanna Vera
Senior Licensing Manager 

Ethypharm United Kingdom

Ethypharm is a rapidly growing specialty pharma company with nascent commercial operations, an expanding portfolio of marketed products, a unique drug development expertise and a broad and advanced pipeline.

Ethypharm now incorporating Martindale Pharma of the UK focuses on pain management and treatment for addiction, particularly opioids and alcohol use disorder; with the current short-term goal to commercialize its own or in-licensed drugs in a number of European countries.

In other therapeutic areas, mainly oncology, Ethypharm has a strong capability in developing and manufacturing specific and "complex" drug formulations in order to market them through global or local partners.

Ethypharm’s headquarters are located in Paris, France and has a very strong affiliate in the UK, it owns two manufacturing plants in France, one in China, and an affiliate in the USA.
Ethypharm is actively seeking:

• Licensing-in/acquisition opportunities in pain and addiction (to opioids, alcohol, tobacco) , critical care, complex generics, brands, late stage NCEs, Steriles/Injectables, Hospital products);

Dr John Coates
Business Devlopment Director